Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.

Share Sales Rebound 98% in Toronto as Copper, Gold Prices SurgePrivate Credit Titans Pack Middle East Flights to Chase BillionsMillennium, Point72 and Citadel Are Among Buyers of Bitcoin ETFsMoneyGram Joins Repricing Bonanza With $398 Million LoanBernanke and Blanchard Say Central Banks Need Cooler Job MarketsRenaissance Technologies Piled Into GameStop, AMC Ahead of RallyJane Street Ordered to Detail Secret India Trading StrategyFunds Managed by Bank Trust Departments Draw Scrutiny From SECUS...

1 Billion Deal for SilverBowThe Daily Chase: Canada's Crypto King arrested on fraud chargesU.S. core CPI cools for first time in 6 months in relief for Fed'I'm bullish on commodities': Portfolio manager on the state of the Canadian dollarStatistics Canada reports wholesale sales down 1.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines